Tvardi Therapeutics (TVRD) Retained Earnings: 2013-2016
Historic Retained Earnings for Tvardi Therapeutics (TVRD) over the last 4 years, with Dec 2016 value amounting to -$162.2 million.
- Tvardi Therapeutics' Retained Earnings fell 1030920.00% to -$206.2 million in Q3 2017 from the same period last year, while for Sep 2017 it was -$206.2 million, marking a year-over-year decrease of 1030920.00%. This contributed to the annual value of -$162.2 million for FY2016, which is 463245.71% down from last year.
- According to the latest figures from FY2016, Tvardi Therapeutics' Retained Earnings is -$162.2 million, which was down 463,245.71% from -$35,000 recorded in FY2015.
- In the past 5 years, Tvardi Therapeutics' Retained Earnings registered a high of -$35,000 during FY2015, and its lowest value of -$162.2 million during FY2016.
- Over the past 3 years, Tvardi Therapeutics' median Retained Earnings value was -$80.2 million (recorded in 2014), while the average stood at -$80.8 million.
- Per our database at Business Quant, Tvardi Therapeutics' Retained Earnings spiked by 99.96% in 2015 and then slumped by 463,245.71% in 2016.
- Tvardi Therapeutics' Retained Earnings (Yearly) stood at -$62.5 million in 2013, then declined by 28.41% to -$80.2 million in 2014, then soared by 99.96% to -$35,000 in 2015, then plummeted by 463,245.71% to -$162.2 million in 2016.